• SENSEX 77,243.67
    310.08 (+0.40%)
  • BANKNIFTY 57,509.95
    -273.80 (--0.47%)
  • Premier Energies
    973.20 660.80(%)
  • Capri Global
    257.15 264.60(%)
  • Titan Company
    5,168.15 5,187.45(%)
  • Tejas Networks
    576.80 644.75(%)
  • MV Electrosystems
    743.30 686.65(%)
  • Cams Services
    750.95 844.80(%)
  • Shyam Metalics
    1,098.80 1,089.60(%)
  • Emcure Pharma
    1,856.90 1,260.10(%)
  • Ather Energy
    1,614.85 1,589.40(%)
  • Netweb Technol.
    5,450.00 5,810.00(%)
  • Astra Microwave
    1,670.50 835.90(%)
  • Lenskart Solut.
    647.95 673.35(%)
  • TCS
    2,335.00 3,336.70(%)
  • Tata Steel
    186.20 153.00(%)
  • HDFC Bank
    715.25 1,020.35(%)
  • Escorts Kubota
    3,027.00 4,171.35(%)
  • HEG
    740.00 749.00(%)
  • ZF Commercial
    2,540.80 2,053.38(%)
  • Infosys
    1,144.65 1,727.85(%)
  • Triveni Turbine
    579.75 428.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Hester Biosciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4164.0
  • ISIN : INE782E01017
2,289.80 -65 (-2.74%)
  • As on 28 Aug 2026 (EOD)

  • Today’s Low

    2,270.20

  • Today’s High

    2,359.20

  • Open

    2,336.70

  • Perv Close

    2,354.40

  • 52W Low

    1,239.30

  • 52W High

    2,683.60

Key Indicators

  • P/E(TTM)

    36.43

  • Mar.Cap (₹Cr.)

    1,947.90

  • Div & Yield %

    0.48

  • Book Value(₹)

    452.79

  • Debt-Equity Ratio

    -2.74

  • AGM Date

    27-Aug-2026

  • EPS

    63.10

  • P/E Ratio

    36.43

Financials Ratios

  • Debt-Equity Ratio

    0.91

  • Mar.Cap (₹Cr.)

    1,947.90

  • RONW (%)

    7.41

  • ROCE (%)

    8.74

Score Board

  • Equity (₹ in Cr.)

    8.51

  • BV (₹)

    452.80

  • Sales( ₹ in Cr.)

    292.14

  • NP (in Cr.)

    47.02

  • NP Var(%)

    46.0

  • Div%

    110.0

  • CPS (₹)

    67.30

  • EPS (₹)

    55.30

  • Traded Value (₹ in Lakhs)

    1,955.73

  • 52 Week High

    2,683.60

  • 52 Week Low

    1,239.30

  • Price BSE

    2299.0

  • Price NSE

    2,290.00

  • Market Capital( in Cr.)

    1,955.73

  • P/C Ratio

    34.10

  • P/E Ratio

    41.60

  • Price Vs.BV

    55.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 292.14 286.47 285.16 254.00 219.35 208.48
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 292.14 286.47 285.16 254.00 219.35 208.48
Other Income 14.63 4.76 4.26 5.32 4.66 1.65
Stock Adjustments 3.69 -9.97 -10.36 4.77 12.53 -4.01
Total Income 310.46 281.26 279.06 264.09 236.54 206.12
EXPENDITURE :            
Raw Materials 85.66 83.70 89.28 84.65 76.37 49.38
Power and Fuel Cost 9.20 10.12 12.34 9.95 8.74 6.93
Employee Cost 53.17 54.76 56.72 47.92 39.12 33.45
Other Manufacturing Expenses 15.23 14.07 14.49 7.57 6.89 5.46
Selling and Administration Expenses 49.88 54.45 50.25 49.26 34.94 32.24
Miscellaneous Expenses 10.21 8.46 4.37 4.55 5.26 10.28
Employee Benefit Expenses 53.17 54.76 56.72 47.92 39.12 33.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 223.36 225.56 227.45 203.88 171.31 137.74
Operating Profit 87.10 55.71 51.60 60.21 65.23 68.37
Interest 7.17 5.37 5.09 6.50 2.47 3.95
Gross Profit 79.93 50.34 46.51 53.71 62.76 64.42
Depreciation 10.25 8.58 9.78 9.79 9.50 9.63
Profit Before Tax 69.68 41.76 36.73 43.92 53.26 54.79
Current Tax 14.47 11.27 9.64 10.73 14.25 16.37
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.12 -1.35 -0.06 0.86 -0.51 -1.48
Reported Net Profit 52.10 31.84 27.16 32.34 39.52 39.90
Extraordinary Items 5.08 -0.35 0.02 0.01 0.09 -3.69
Adjusted Net Profit 47.02 32.19 27.14 32.33 39.43 43.59
Adjustment below Net Profit -0.05 -0.36 -0.02 0.11 -0.16 0.21
P & L Balance brought forward 272.91 246.53 226.20 202.25 171.40 136.90
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 5.96 5.10 6.81 8.51 8.51 5.62
P & L Balance carried down 319.00 272.91 246.53 226.20 202.25 171.40
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 110.00 70.00 60.00 80.00 100.00 100.00
Dividend Per Share(Rs) 11.00 7.00 6.00 8.00 10.00 10.00
Earnings Per Share-Unit Curr 61.24 37.43 31.93 38.02 46.45 46.90
Earnings Per Share(Adj)-Unit Curr 61.24 37.43 31.93 38.02 46.45 46.90
Book Value 452.78 398.60 367.59 343.70 315.54 279.28
Book Value(Adj)-Unit Curr 452.78 398.60 367.59 343.70 315.54 279.28

Shareholding Pattern

  • Promoter Group

    53.73%

  • Public Share Holding

    46.27%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 803,955 803,955.00 803,955 803,955
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 803,955 9.45 803,955 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 272,838 3.21 272,838 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,430,151 40.32 3,430,151 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,766,989 44.28 3,766,989 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 26,736 0.31 26,736 16
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 158 0.00 158 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 26,894 0.32 26,894 18
2] Non Institution
Bodies Corporate 230,233 2.71 230,232 114
Clearing Members 49,098 0.58 49,098 10
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 506,388 5.95 506,388 429
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 212,748 2.50 212,648 331
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,240,318 14.58 1,240,318 16
Individuals holding nominal share capital up to Rs. 1 lakh 1,567,108 18.42 1,510,917 11,015
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,499 0.03 2,499 1
Others 86,431 1.02 86,431 2
Sub Total 3,909,027 45.95 3,852,735 11,930
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,506,865 100.00 8,450,573 11,961

Company Background

Hester Biosciences LtdPharmaceuticals - Indian - Formulations

  • Hester Biosciences Ltd
  • BSE Code : 4164.0
  • ISIN : INE782E01017

  • Incorporation Year

    1987

  • Registered Office

    1st Flr PushpakPachvati Circle
    Motilal Hirabhai Road, Ahmedabad,
    Gujarat-380006

  • Telephone

    91-079-26445107

  • FAX

    91-079-26445105

  • Chairman

    Bhupendra V Gandhi

  • Managing Director

  • Company Secretary

    Vinod Mali

  • Auditor

    Chandulal M Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Hester Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Hester Bios 2,299.00 299.77 292.14 33.17 15.28
Abbott India 26,378.40 7,217.19 6,929.05 34.72 43.78
Astrazeneca Phar 7,121.10 2,304.07 2,275.58 104.95 27.86
Glaxosmi. Pharma 3,068.35 3,932.76 3,790.20 49.02 58.17
Novartis India 1,494.10 398.23 356.27 37.73 16.64
Cipla 1,419.90 20,102.60 18,979.95 37.32 13.88
Bliss GVS Pharma 559.10 773.53 729.81 51.91 12.51
Amrutanjan Healt 516.40 469.50 451.82 27.66 21.89
Fermenta Biotec. 486.15 474.15 450.25 22.70 18.77
Guj. Themis Bio. 412.90 152.47 150.80 92.37 27.21
Ambalal Sarabhai 43.91 19.52 3.94 81.31 6.77